Concepedia
Statistics
Publications
19
Citations
1.1K
H-Index
18
Active since
1988
Affiliations
Bristol-Myers Squibb (United States)(Current)
Bristol-Myers Squibb (Germany)
Eli Lilly (United States)
Wallingford Public Library
Kuo‐Long Yu is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, medicinal chemistry, and virology.
Publications per year
1988–2010
A novel reagent for the synthesis of -inositol phosphates: ,-diisopropyl dibenzyl phosphoramidite
Kuo‐Long Yu, Bert Fraser‐Reid · Tetrahedron Letters · 1988 · 173 citations
Pharmacy, Biochemistry, Natural Product Biosynthesis +3
Orally Active Fusion Inhibitor of Respiratory Syncytial Virus
Christopher Cianci, Kuo‐Long Yu, Keith D. Combrink et al. · Antimicrobial Agents and Chemotherapy · 2004 · 140 citations · Full text
Pharmacy, Infectious Diseases, Medicinal Chemistry +17
Targeting a binding pocket within the trimer-of-hairpins: Small-molecule inhibition of viral fusion
Christopher Cianci, David R. Langley, Douglas D. Dischino et al. · Proceedings of the National Academy of Sciences · 2004 · 103 citations · Full text
Life Sciences, Biology, Molecular Biology +15
Oral Efficacy of a Respiratory Syncytial Virus Inhibitor in Rodent Models of Infection
Christopher Cianci, Eugene V. Genovesi, Lucinda Lamb et al. · Antimicrobial Agents and Chemotherapy · 2004 · 78 citations · Full text
Medicine, Infectious Diseases, Pharmacology +17
Respiratory syncytial virus fusion inhibitors. Part 4: Optimization for oral bioavailability
Kuo‐Long Yu, Ny Sin, Rita L. Civiello et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 72 citations
Pharmacy, Pharmacokinetics, Pharmacology +14
1–5 of 19